Roadside Drug Testing Devices

Roadside Drug Testing Devices Market Outlook

The global roadside drug testing devices market is projected to reach USD 4.2 billion by 2035, growing at a CAGR of 6.5% from 2025 to 2035. The increasing prevalence of substance abuse, coupled with stringent government regulations aimed at ensuring road safety, is driving the growth of this market. Additionally, advancements in testing technologies and a growing emphasis on workplace safety and drug-free environments are further propelling market expansion. The rising number of road accidents associated with intoxication, particularly in urban areas, has led to heightened awareness and the implementation of roadside drug testing measures by law enforcement agencies. Collectively, these factors are fostering a conducive environment for the growth of the roadside drug testing devices market.

Growth Factor of the Market

The growth of the roadside drug testing devices market is underscored by several key factors. Firstly, the increasing incidence of drug-related road accidents has compelled law enforcement agencies worldwide to adopt more rigorous testing methods to ensure public safety. Secondly, technological advancements have led to the development of highly sensitive and rapid testing devices, enhancing their appeal to various stakeholders, including law enforcement and employers. Thirdly, the growing awareness regarding the implications of drug abuse in workplaces is pushing organizations to implement drug testing protocols more stringently. Additionally, the COVID-19 pandemic has highlighted the need for alternative testing methods, further driving the adoption of roadside drug testing devices. Lastly, governmental initiatives aiming to combat drug abuse and promote road safety have created a favorable regulatory landscape for the market.

Key Highlights of the Market

• The global roadside drug testing devices market is expected to grow significantly, reaching USD 4.2 billion by 2035.
• Technological advancements are enhancing the sensitivity and speed of drug testing devices.
• Increased government mandates for roadside testing are driving market penetration.
• Law enforcement agencies are the primary end-users, followed by workplaces and healthcare facilities.
• North America holds the largest market share, supported by stringent regulations and high awareness levels.

By Product Type

Breathalyzer:

Breathalyzers are one of the most commonly used roadside drug testing devices, designed to measure the blood alcohol concentration (BAC) of individuals through their breath. They operate on the principle of detecting alcohol vapors and converting them into a quantitative measurement of BAC. The convenience and speed of breathalyzers make them particularly appealing for use in roadside tests, allowing law enforcement officers to quickly assess whether a driver is impaired. Furthermore, advancements in breathalyzer technology have resulted in devices that can also detect the presence of drugs, broadening their applications beyond alcohol testing. This versatility is expected to drive the demand for breathalyzers in the market.

Oral Fluid Testing Devices:

Oral fluid testing devices offer a non-invasive method for drug detection by analyzing saliva samples. These devices have gained popularity due to their ease of use, rapid results, and ability to detect a wide array of substances, including opioids, marijuana, and stimulants. As the need for immediate and accurate drug testing increases, oral fluid testing devices are increasingly being adopted by law enforcement agencies and employers. The ability to administer tests at the roadside without requiring specialized training or laboratory facilities further enhances their appeal. This segment of the market is expected to experience significant growth as more organizations recognize the benefits of oral fluid testing.

Urine Drug Testing Devices:

Urine drug testing devices are traditionally one of the most prevalent forms of drug testing and are commonly used in various settings, including workplaces and rehabilitation centers. These devices offer the ability to detect a wide range of drugs over a longer detection window compared to other testing methods. While urine testing can typically provide reliable results, it often requires more time and infrastructure than other roadside testing methods. However, with technological advancements, rapid urine drug testing kits are now available, allowing for quicker results while maintaining accuracy. This segment is expected to see steady growth as organizations continue to implement urine testing as part of comprehensive drug testing programs.

Hair Drug Testing Devices:

Hair drug testing devices are used to analyze hair samples for the presence of drugs over an extended period, typically up to 90 days. This type of testing is particularly beneficial for identifying long-term drug use rather than recent consumption. Although less common in roadside testing, hair testing is gaining traction in workplace drug testing due to its ability to provide a comprehensive history of substance use. The major advantage of hair drug testing is that it is less prone to tampering compared to other methods. As organizations look for thorough drug testing solutions, the hair drug testing segment is expected to witness gradual growth driven by an increasing focus on substance abuse prevention and employee wellness.

Sweat Drug Testing Devices:

Sweat drug testing devices utilize sweat samples to detect drug use over time, making them an innovative and non-invasive option for monitoring substance abuse. These devices are often used in correctional facilities, rehabilitation programs, and workplaces where ongoing monitoring is essential. Their ability to provide continuous drug detection by wearing a patch for an extended period is a significant advantage, as it allows for real-time monitoring without requiring frequent tests. The growing emphasis on maintaining drug-free environments in various sectors is expected to drive interest and adoption of sweat drug testing devices, contributing to the market's overall growth.

By Application

Law Enforcement Agencies:

Law enforcement agencies represent a significant segment in the roadside drug testing devices market, primarily due to the critical role these devices play in ensuring road safety. Officers increasingly rely on drug testing devices during traffic stops to assess drivers' sobriety quickly. The rise in drug-related accidents has led to more stringent enforcement of DUI laws, prompting agencies to adopt advanced testing methods. Furthermore, governmental initiatives aimed at reducing impaired driving have resulted in increased funding and support for law enforcement agencies to procure the necessary testing equipment. This sustained demand from law enforcement is a crucial driver for market growth.

Workplaces:

In workplace environments, drug testing is a vital component of ensuring employee safety and maintaining productivity. Companies across various industries implement drug testing programs to create a safe working environment and mitigate risks associated with substance abuse. Roadside drug testing devices are being increasingly adopted in industries such as transportation, where impaired employees can pose significant dangers to both themselves and the public. The growing focus on workplace safety regulations and drug-free workplace policies is leading organizations to invest in effective drug testing solutions. This trend is expected to propel the growth of roadside drug testing devices within the workplace application segment.

Hospitals:

Hospitals are increasingly utilizing roadside drug testing devices as part of their emergency care protocols. In situations involving accidents or acute medical conditions, it is crucial to determine whether a patient’s condition is influenced by substance use. Rapid drug testing devices enable healthcare professionals to receive timely results, allowing for appropriate medical interventions. Additionally, hospitals are integrating drug testing into their routine care for patients with a history of substance abuse, reinforcing the importance of early detection and treatment. As healthcare providers strive to improve patient outcomes, the incorporation of roadside drug testing devices within hospital settings is expected to grow.

Drug Rehabilitation Centers:

Drug rehabilitation centers rely on drug testing devices to monitor patients' substance use and compliance with treatment protocols. Regular testing is essential for identifying relapses and tailoring interventions for effective recovery. Roadside drug testing devices offer rehabilitation facilities the ability to conduct rapid testing, ensuring that patients are held accountable for their recovery journey. Moreover, as rehabilitation programs evolve to incorporate evidence-based practices, the demand for reliable drug testing solutions within these centers is anticipated to rise significantly. This focus on patient monitoring and support is expected to contribute positively to the growth of the roadside drug testing devices market.

Others:

Other applications of roadside drug testing devices include sports organizations and educational institutions. In sports, anti-doping agencies are increasingly utilizing drug testing to ensure fair competition and maintain athlete integrity. Similarly, educational institutions are implementing drug testing within extracurricular activities to promote a drug-free environment. These applications contribute to the overall demand for roadside drug testing devices, as the need for accurate and timely drug detection continues to expand across various sectors. As awareness regarding the impact of drug abuse rises, the scope for these testing devices is likely to broaden, driving additional growth within the market.

By Distribution Channel

Online Stores:

Online stores have become a prominent distribution channel for roadside drug testing devices, driven by the convenience and accessibility they offer. As more consumers and organizations turn to online shopping for their procurement needs, vendors have expanded their digital presence to meet this demand. The availability of a wide range of products on online platforms allows customers to compare prices, read reviews, and make informed purchasing decisions. Moreover, online sales often come with competitive pricing and promotional offers, making it an attractive option for buyers. This growth in online distribution channels is expected to further accelerate the expansion of the roadside drug testing devices market.

Specialty Stores:

Specialty stores, including medical supply stores and safety equipment retailers, play a crucial role in distributing roadside drug testing devices. These stores cater to specific customer needs, providing expert knowledge and personalized service that online platforms may lack. Customers often prefer purchasing from specialty stores to obtain professional advice regarding the selection and use of drug testing devices. Furthermore, specialty stores often stock the latest technologies and brand offerings, appealing to businesses and organizations looking for high-quality products. The continued demand for specialized knowledge and personalized service is likely to strengthen the position of specialty stores in the roadside drug testing devices market.

Hospitals/Clinics:

Hospitals and clinics serve as vital distribution channels for roadside drug testing devices, especially in the context of healthcare applications. These establishments require reliable and effective drug testing equipment to enhance their medical protocols and patient care processes. Direct procurement by hospitals and clinics ensures that testing devices are readily available in urgent situations, particularly in emergency departments. Additionally, as healthcare professionals increasingly recognize the importance of drug screening in patient evaluations, the demand for testing devices within these facilities is expected to grow. This segment will continue to contribute significantly to the overall roadside drug testing devices market.

Others:

Other distribution channels for roadside drug testing devices include wholesalers and distributors who specialize in supplying testing equipment to various sectors. These intermediaries play a crucial role in ensuring that products reach end-users efficiently, especially in regions where direct access to manufacturers may be limited. By leveraging their networks, wholesalers can offer competitive pricing and bulk purchasing options, appealing to organizations looking to invest in drug testing solutions. The reliance on distributors to bridge the gap between manufacturers and end-users is expected to sustain the growth of this segment within the roadside drug testing devices market.

By Technology

Immunoassay Analyzers:

Immunoassay analyzers are a critical technology used in roadside drug testing devices for their ability to detect specific drugs and their metabolites in biological samples. These analyzers work on the principle of antigen-antibody interactions, which allows for the quantification of substances present in the sample. The high sensitivity and specificity of immunoassay technologies make them an ideal choice for initial screening processes in drug testing. As the demand for accurate and reliable drug testing continues to grow, the adoption of immunoassay analyzers is expected to witness significant growth in the roadside drug testing devices market.

Chromatography Instruments:

Chromatography instruments are utilized in advanced drug testing methodologies, providing a high level of accuracy in identifying and quantifying a wide range of substances. These instruments separate different components in a sample, allowing for detailed analysis and reliable results. Although primarily used in laboratory settings, the advancements in portable chromatography technology are making it feasible for roadside applications as well. The growing shift towards more sophisticated testing techniques that offer definitive results will drive the adoption of chromatography instruments in the roadside drug testing devices market.

Breath Analyzers:

Breath analyzers are specialized devices that measure the concentration of alcohol and other substances in a person's breath. Their rapid testing capability and ease of use are major advantages, making them a preferred choice for roadside testing by law enforcement. The continuous innovation in breath analyzer technology, including the integration of drug detection capabilities, is anticipated to increase their relevance in the roadside drug testing devices market. As public safety concerns rise, the demand for accurate and immediate results from breath analyzers is expected to drive their market growth.

Oral Fluid Testing Devices:

Oral fluid testing devices are becoming increasingly important in the roadside drug testing landscape due to their non-invasive nature and quick results. These devices analyze saliva samples, making them easy to administer in various settings, including roadside checks. The ability to detect multiple substances in a single test further enhances their utility. With advances in technology making oral fluid testing more reliable and efficient, this segment is expected to continue gaining traction, playing a vital role in the overall roadside drug testing devices market.

Others:

Other technologies used in roadside drug testing devices include various innovative methodologies that enhance detection capabilities, such as infrared spectroscopy and mass spectrometry. These technologies provide high accuracy and can analyze complex samples for a wide range of substances. Although they may not be as commonly used in immediate roadside testing due to their complexity and need for laboratory settings, the innovations in these areas can support more comprehensive testing approaches. As the demand for precise drug detection grows, these advanced technologies will likely influence the roadside drug testing devices market in the long run.

By Region

North America currently dominates the roadside drug testing devices market, accounting for approximately 42% of the global share. This significant portion is attributed to stringent regulations around substance testing and high public awareness regarding the dangers of drug-impaired driving. The region has seen substantial investment in drug testing technology, supported by government initiatives and law enforcement agencies' proactive measures. Furthermore, the continuous advancement in testing technology, coupled with high consumer acceptance, positions North America as a leader in this market. The CAGR for the North American market is projected to be around 6.2% from 2025 to 2035, reflecting robust growth potential.

Europe holds the second-largest market share for roadside drug testing devices, contributing approximately 31% to the global market. The growth in this region is driven by increasing public and governmental awareness of drug use implications on road safety. European countries are implementing stricter drug testing laws and regulations, further boosting the demand for testing devices. Moreover, the collaborative efforts of law enforcement agencies and healthcare institutions in promoting drug-free environments play a pivotal role in market expansion. As the European market continues to evolve, it is anticipated to grow at a CAGR of around 6.8% during the forecast period, indicating a solid growth trajectory.

Opportunities

The roadside drug testing devices market presents numerous opportunities driven by the evolving regulatory landscape and the rising public awareness concerning substance abuse. Governments across the globe are implementing stricter laws related to drug testing, especially concerning road safety. This trend is expanding the market for roadside drug testing devices, as law enforcement agencies seek reliable and efficient tools to enforce these regulations. Additionally, the increasing focus on workplace safety and the need for drug-free environments create demand for testing devices across various industries, including transportation and construction. Companies are increasingly integrating regular drug testing into their HR policies, creating a further opportunity for the roadside drug testing market.

Another significant opportunity lies in technological advancements that enhance the accuracy, speed, and usability of roadside drug testing devices. As manufacturers innovate and develop more portable and user-friendly testing solutions, the potential for widespread adoption increases. The integration of digital technologies, such as mobile applications for data management and reporting, is also an emerging trend. These developments not only improve the overall efficiency of drug testing but also enhance the user experience. Moreover, as more stakeholders recognize the benefits of rapid and accurate drug detection, the market's growth potential is set to increase significantly, providing a broad spectrum of opportunities for existing and new players.

Threats

Despite the positive growth outlook, the roadside drug testing devices market faces certain threats that could hinder its progress. One significant threat is the potential for regulatory changes or inconsistencies across different regions, which can create challenges for manufacturers and users of drug testing devices. The lack of universal standards for testing methods can lead to confusion and hinder the implementation of testing protocols, ultimately affecting market growth. Additionally, public skepticism regarding the accuracy and reliability of roadside testing devices may impact their acceptance and utilization, especially in jurisdictions that have not fully embraced such technologies.

Moreover, the rapid evolution of drug formulations, including synthetic drugs that may not be detectable by conventional testing methods, presents a challenge for manufacturers. As drug users continually adapt to evade detection, there is a need for constant innovation in testing technologies to keep pace with these changes. This requirement for continuous investment in research and development could strain smaller manufacturers and limit their ability to compete in the market. Addressing these challenges will be crucial for the sustained growth and success of the roadside drug testing devices market.

Competitor Outlook

• Alere Inc.
• Abbott Laboratories
• Thermo Fisher Scientific Inc.
• Drägerwerk AG & Co. KGaA
• Quest Diagnostics Inc.
• AccuBioTech Co., Ltd.
• OraSure Technologies, Inc.
• RCM Health Care Services
• Securetec Detektions-Systeme AG
• Hound Labs, Inc.
• LabCorp
• Maricopa County Sheriff’s Office
• Intoximeters, Inc.
• Concentra, Inc.
• Microgenics Corporation

The competitive landscape of the roadside drug testing devices market is characterized by a mix of established players and emerging companies striving to innovate and enhance their product offerings. Major companies dominate the market, leveraging their extensive research and development capabilities to introduce advanced testing technologies. These companies often engage in strategic partnerships and collaborations to expand their market reach and enhance their product portfolios. Additionally, the increasing emphasis on public safety and regulatory compliance has encouraged these firms to invest significantly in developing reliable and efficient drug testing solutions. The overall competition is expected to intensify as new entrants try to carve out a niche in this growing market.

Among the key players, Drägerwerk AG & Co. KGaA stands out for its dedication to innovation in drug testing technology. The company offers a wide range of portable drug testing devices that cater to various sectors, including law enforcement and workplace safety. Its commitment to quality and reliability has positioned Dräger as a trusted name in roadside drug testing, ensuring customer satisfaction and adherence to regulatory standards. In addition to its robust product lineup, Dräger engages in continuous research efforts to enhance its technologies and provide users with the most effective solutions available in the market.

Abbott Laboratories is another prominent player in the roadside drug testing devices market, known for its cutting-edge immunoassay analyzers and rapid testing solutions. The company's strong presence in the healthcare sector allows it to leverage its expertise in diagnostics to address the growing demand for roadside testing devices. Abbott's commitment to innovation has resulted in the development of highly sensitive testing kits that can accurately detect various substances. Its strategic collaborations with law enforcement and healthcare organizations further enhance its market position, enabling Abbott to deliver comprehensive solutions for drug testing in diverse applications.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 LabCorp
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Alere Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Concentra, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Hound Labs, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Intoximeters, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Abbott Laboratories
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 AccuBioTech Co., Ltd.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Quest Diagnostics Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Microgenics Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 RCM Health Care Services
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 OraSure Technologies, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Thermo Fisher Scientific Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Drägerwerk AG & Co. KGaA
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Securetec Detektions-Systeme AG
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Maricopa County Sheriff’s Office
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Roadside Drug Testing Devices Market, By Technology
    • 6.1.1 Immunoassay Analyzers
    • 6.1.2 Chromatography Instruments
    • 6.1.3 Breath Analyzers
    • 6.1.4 Oral Fluid Testing Devices
    • 6.1.5 Others
  • 6.2 Roadside Drug Testing Devices Market, By Application
    • 6.2.1 Law Enforcement Agencies
    • 6.2.2 Workplaces
    • 6.2.3 Hospitals
    • 6.2.4 Drug Rehabilitation Centers
    • 6.2.5 Others
  • 6.3 Roadside Drug Testing Devices Market, By Product Type
    • 6.3.1 Breathalyzer
    • 6.3.2 Oral Fluid Testing Devices
    • 6.3.3 Urine Drug Testing Devices
    • 6.3.4 Hair Drug Testing Devices
    • 6.3.5 Sweat Drug Testing Devices
  • 6.4 Roadside Drug Testing Devices Market, By Distribution Channel
    • 6.4.1 Online Stores
    • 6.4.2 Specialty Stores
    • 6.4.3 Hospitals/Clinics
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Roadside Drug Testing Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Roadside Drug Testing Devices market is categorized based on

By Product Type

• Breathalyzer
• Oral Fluid Testing Devices
• Urine Drug Testing Devices
• Hair Drug Testing Devices
• Sweat Drug Testing Devices

By Application

• Law Enforcement Agencies
• Workplaces
• Hospitals
• Drug Rehabilitation Centers
• Others

By Distribution Channel

• Online Stores
• Specialty Stores
• Hospitals/Clinics
• Others

By Technology

• Immunoassay Analyzers
• Chromatography Instruments
• Breath Analyzers
• Oral Fluid Testing Devices
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Alere Inc.
• Abbott Laboratories
• Thermo Fisher Scientific Inc.
• Drägerwerk AG & Co. KGaA
• Quest Diagnostics Inc.
• AccuBioTech Co., Ltd.
• OraSure Technologies, Inc.
• RCM Health Care Services
• Securetec Detektions-Systeme AG
• Hound Labs, Inc.
• LabCorp
• Maricopa County Sheriff’s Office
• Intoximeters, Inc.
• Concentra, Inc.
• Microgenics Corporation